Evidence map›Paper›PMID 31516851›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2019

Protatranes, effective growth biostimulants of hydrocarbon-oxidizing bacteria from Lake Baikal, Russia.

Olga N Pavlova, Sergey N Adamovich, Angelina S Novikova, Alexander G Gorshkov, Oksana N Izosimova, Igor A Ushakov, Elizaveta N Oborina, Anna N Mirskova, Tamara I Zemskaya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olga N PavlovaLimnological Institute, Siberian Branch, Russian Academy of Sciences, 3, Ulan-Batorskaya, 664033, Irkutsk, Russia.
Sergey N AdamovichA.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 1, Favorsky st., 664033, Irkutsk, Russia.
Angelina S NovikovaLimnological Institute, Siberian Branch, Russian Academy of Sciences, 3, Ulan-Batorskaya, 664033, Irkutsk, Russia.
Alexander G GorshkovLimnological Institute, Siberian Branch, Russian Academy of Sciences, 3, Ulan-Batorskaya, 664033, Irkutsk, Russia.
Oksana N IzosimovaLimnological Institute, Siberian Branch, Russian Academy of Sciences, 3, Ulan-Batorskaya, 664033, Irkutsk, Russia.
Igor A UshakovA.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 1, Favorsky st., 664033, Irkutsk, Russia.
Elizaveta N OborinaA.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 1, Favorsky st., 664033, Irkutsk, Russia.
Anna N MirskovaA.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 1, Favorsky st., 664033, Irkutsk, Russia.
Tamara I ZemskayaLimnological Institute, Siberian Branch, Russian Academy of Sciences, 3, Ulan-Batorskaya, 664033, Irkutsk, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Under natural conditions, biodegradation processes proceed slowly, especially in regions with low temperature. To activate vital processes in hydrocarbon-oxidizing microorganisms at low temperatures, biologically active compounds can be employed as growth stimulants. A low-temperature (10 °C) study has shown that tris-(2 hydroxyethyl) ammonium arylchalcogenylacetates, "protatranes" exert an effect on the growth of hydrocarbon-oxidizing strains of

Indexed as

Arylchalcogenylacetic acidsHydrocarbon-oxidizing bacteriaLake BaikalProtatranesStimulantsTris(2-hydroxyethyl)ammonium salts

Identifiers

PMID31516851
PMCPMC6732725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.